COVID-19 in a pregnant kidney transplant recipient - what we need to know: A case report

Table 1 Patients’ characteristics

Variables at presentation	Values
Demographics
Age, yr	37
Sex	Female
Race	White
Number of KT	3
Primary nephropathy	Focal and segmental glomerulosclerosis
Causes of previous KT losses	Chronic rejection
Time from last KT	24 mo
Comorbidities	Arterial hypertension
Pregnancy
Gestation age, wk	20
Fetal grow	Regular
Symptoms/signs
Fever, T > 37.5 °C	Yes
Dyspnea	Yes
Anosmia	Yes
Myalgias	Yes
SARS-CoV-2 status
SARS-CoV-2 swab test positive	Yes (positivity for 40 d)
SARS-CoV-2 vaccination	No
Biochemical tests
At infection diagnosis
Creatinine, mg/dL	1.18
WBC as × 103/mmc	7.640
Lymphocytes, cells/mmc	1.590
PTL as × 103/mmc	202
C-reactive protein, mg/L	10.1
Procalcitonin, ng/mL	0.52
Peak during infection
Creatinine, mg/dL	1.3
WBC as × 103/mmc	12.700
Lymphocytes, cells/mmc	3.400
PTL as × 103/mmc	250
C-reactive protein, mg/L	20.2
Procalcitonin, ng/mL	2.01
Immunosuppression regimen
Tacrolimus	Continued at unchanged doses (target levels: 7-8 μmol/L)
Azathioprine	Withdrawal
Steroids	Continued at unchanged doses (5 mg/d)
Outcomes
Recovery from COVID-19 disease, mo	1
De novo DSA after SARS-CoV-2 infection	No
Rejection episode	No
Delivery
Time of delivery, wk	39
Newborn status	Healthy, no complication
Time of follow-up after infection, mo	17
Renal function at last follow-up
Creatinine, mg/dL	1.09

COVID-19: Coronavirus disease 2019; DSA: Donor-specific antibody; KT: Kidney transplant; PTL: Primary testicular lymphoma; SARS-CoV-2: Severe acute respiratory syndrome coronavirus; WBC: White blood cell.